Results 31 to 40 of about 63,556 (301)

“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy

open access: yesModern Pathology, 2019
Different clones, protocol conditions, instruments, and scoring/readout methods may pose challenges in introducing different PD-L1 assays for immunotherapy.
E. Torlakovic   +31 more
semanticscholar   +1 more source

An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability

open access: yesDrug Design, Development and Therapy, 2021
Biologic drugs have revolutionized the treatment of psoriasis and other rheumatological diseases. In recent years, many biosimilar agents that are highly similar in structure and function to their originator products have been developed, including the ...
Xin Zhou, Zhuo Chen, X. Bi
semanticscholar   +1 more source

Digital interchangeability design of aircraft control surfaces

open access: yesHangkong gongcheng jinzhan
With the gradual maturity and application of digital assembly technology,the interchangeability design adapting to digital quantity transfer is of significant practical significance for improving the efficiency of aircraft control surface design ...
LI Yunpeng, YAO Xionghua, GAO Shuai
doaj   +1 more source

Interchangeability of position tracking technologies; can we merge the data?

open access: yesScience and medicine in football, 2020
Purpose: The purpose of this study was to assess the interchangeability of position tracking metrics obtained using global positioning systems (GPS) versus those obtained by a semi-automatic high definition (HD) optical camera system.
M. Taberner   +7 more
semanticscholar   +1 more source

Comparison of Hematological and Biochemical Results Derived from Arterial and Venous Blood Samples in Post-Anesthetic Dogs

open access: yesAnimals, 2020
Collecting blood from an indwelling arterial catheter may reduce stress from repeated venipuncture in patients requiring serial monitoring, but the use of arterial blood for hematological and biochemical testing remains understudied.
Song Mi Lee   +3 more
doaj   +1 more source

Update on Non-Interchangeability of Botulinum Neurotoxin Products

open access: yesToxins
The growing use of botulinum neurotoxins (BoNTs) for medical and aesthetic purposes has led to the development and marketing of an increasing number of BoNT products.
Mitchell F. Brin   +4 more
semanticscholar   +1 more source

An Empirical Analysis of the Perceived Challenges and Benefits of Introducing Biosimilars in Bangladesh: A Paradigm Shift

open access: yesBiomolecules, 2018
The high demand for and resulting financial success of biopharmaceutical products over the last three decades have seen the door open for close copies of these biological products, also known as biosimilars.
Eva Rahman Kabir   +2 more
doaj   +1 more source

Successful implementation of interchange of biologic medications in chronic arthritis after information of costs to prescribers [PDF]

open access: yesExploration of Musculoskeletal Diseases
Aim: To evaluate the impact of prescription, cost, and switching policy on the rate of switching from reference products to biosimilars. Methods: Analysis of an administrative database for prescription in a rheumatology division.
Fernando Perez-Ruiz   +8 more
doaj   +1 more source

Biologics and biosimilars in musculoskeletal diseases: addressing regulatory inconsistencies and clinical uncertainty [PDF]

open access: yesExploration of Musculoskeletal Diseases
Biologics are complex protein-based medications derived from living organisms, used primarily to treat immune-related diseases. Unlike small-molecule drugs synthesized from chemicals, biologics are produced using advanced biotechnology, making their ...
Lauren N. McGrath   +2 more
doaj   +1 more source

Concepts and Challenges of Biosimilars in Breast Cancer: The Emergence of Trastuzumab Biosimilars

open access: yesPharmaceutics, 2018
With the development of anti-human epidermal growth factor receptor 2 (HER2) monoclonal antibodies, trastuzumab-based therapy has become the standard of care among patients with early or advanced HER2-positive breast cancer. However, real-world data have
Alina Uifălean   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy